Microrna Mirna Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_00131686
  • Format: Electronic (PDF)
  • Publish Type: Publish
  • Number of Pages: 250
Home Healthcare microrna mirna market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500
Report Description Table Of Content Research Methodology Download Free Sample

Market Snapshot

CAGR:6.82
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 6.82
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

The MicroRNA (miRNA) Market size is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.72% between 2022 and 2032. The market size is anticipated to increase by USD 2,450.89 million. The growth of the market hinges on several factors, including the expanding understanding of miRNA's role in gene regulation, advancements in molecular biology techniques, and the potential applications of miRNA in disease diagnostics and therapeutic interventions. MicroRNAs are small non-coding RNA molecules that play a crucial role in regulating gene expression by targeting messenger RNAs (mRNAs) for degradation or translational repression.

MicroRNA (miRNA) Market Overview:

Drivers:

One of the key drivers of the miRNA market growth is the increasing recognition of miRNA's significance in various biological processes and disease mechanisms. As research continues to unveil the complex role of miRNAs in gene regulation, their potential as diagnostic biomarkers and therapeutic targets becomes evident. MiRNAs are implicated in numerous diseases, including cancer, cardiovascular diseases, neurodegenerative disorders, and viral infections, opening up opportunities for the development of innovative diagnostic tools and treatment approaches.

Furthermore, advancements in molecular biology techniques, such as Next-Generation Sequencing (NGS) and quantitative polymerase chain reaction (qPCR), have facilitated the profiling and analysis of miRNA expression levels in various biological samples. These techniques offer high-throughput capabilities, enabling researchers to study miRNA expression patterns comprehensively. The combination of technological advancements and increasing research funding is propelling the miRNA market forward.

Trends:

A notable trend shaping the miRNA market is the emergence of liquid biopsy-based diagnostics. Liquid biopsies involve the analysis of miRNAs and other biomolecules present in bodily fluids like blood, urine, and saliva to detect diseases and monitor treatment responses. Liquid biopsy-based diagnostics offer non-invasive and real-time insights into disease progression, enabling early detection and personalized treatment strategies. This trend aligns with the growing demand for minimally invasive diagnostic methods.

Additionally, the integration of artificial intelligence (AI) and bioinformatics in miRNA research is driving the discovery of novel biomarkers and therapeutic targets. AI-driven algorithms can analyze large datasets, identify miRNA-mRNA interactions, and predict their functional implications, accelerating the translation of miRNA research into clinical applications.

Restraints:

Regulatory challenges and ethical considerations surrounding miRNA-based therapies are potential restraints in the market. The complex nature of gene regulation and the potential off-target effects of manipulating miRNAs necessitate rigorous safety and efficacy evaluations. Regulatory agencies require robust preclinical and clinical data to approve miRNA-based therapies, which can lead to longer development timelines and increased costs.

Additionally, the delivery of miRNA-based therapeutics to target tissues poses a challenge. Efficient delivery methods that ensure the specific uptake of therapeutic miRNAs by diseased cells while minimizing off-target effects are still under development.

MicroRNA (miRNA) Market Segmentation By Application:

The cancer diagnostics segment is expected to witness significant growth during the forecast period. MiRNAs have shown potential as biomarkers for cancer detection, prognosis, and monitoring treatment responses. Altered miRNA expression profiles are associated with various cancer types, making them valuable tools for early diagnosis and personalized treatment strategies.

Another notable segment within the miRNA market is cardiovascular diseases. MiRNAs have been implicated in cardiovascular pathologies, and their differential expression patterns in heart tissues and circulating blood can serve as indicators of cardiac health and disease progression.

MicroRNA (miRNA) Market Segmentation By Type:

The microarray-based miRNA profiling segment is projected to experience growth due to its ability to simultaneously analyze the expression of multiple miRNAs. Microarray technology allows researchers to study miRNA expression patterns across various samples, providing insights into miRNA-mediated gene regulation in different physiological and pathological conditions.

Regional Overview:


Download the report summary now!

Request pdf Sample

North America is expected to contribute 40% to the global market growth during the forecast period. The region's well-established life sciences research infrastructure, strong presence of pharmaceutical and biotechnology companies, and high research funding propel the miRNA market in North America. Collaborations between academic institutions and industry players further drive innovation and application development.

Europe also holds a significant market share, driven by the region's focus on personalized medicine and innovative healthcare solutions. The presence of key players and research initiatives in the field of miRNA research further contributes to market growth in Europe.

Major MicroRNA (miRNA) Market Companies:

Companies in the miRNA market are adopting various strategies, including collaborations, acquisitions, and product development, to strengthen their market position.

  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • NanoString Technologies, Inc.
  • Abcam plc
  • Merck KGaA
  • Bioneer Corporation

Segment Overview:

The miRNA market report provides insights into market growth by revenue at global, regional, and country levels. It offers an analysis of trends and growth opportunities from 2019 to 2032.

  • Application Outlook (USD Million, 2019 - 2032)

    • Cancer Diagnostics
    • Cardiovascular Diseases
    • Neurological Disorders
    • Infectious Diseases
    • Others

  • Type Outlook (USD Million, 2019 - 2032)

    • Microarray-based miRNA Profiling
    • PCR-based miRNA Profiling
    • Next-Generation Sequencing (NGS)-based miRNA Profiling

  • Geography Outlook (USD Million, 2019 - 2032)

    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • Japan
    • South America
      • Brazil
    • Middle East & Africa
      • UAE
      • South Africa
      • Rest of Middle East & Africa

TABLE OF CONTENTS: GLOBAL MICRORNA (MIRNA) MARKET

Chapter 1. MARKET SYNOPSIS

1.1. Market Definition

1.2. Research Scope & Premise

1.3. Methodology

1.4. Market Estimation Technique

Chapter 2. EXECUTIVE SUMMARY

2.1. Summary Snapshot, 2016 – 2027

Chapter 3. INDICATIVE METRICS

3.1. Macro Indicators

Chapter 4. MICRORNA (MIRNA) MARKET SEGMENTATION & IMPACT ANALYSIS

4.1. MicroRNA (miRNA) Segmentation Analysis

4.2. Industrial Outlook

4.3. Price Trend Analysis

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

    4.5.1. Power Of Suppliers

    4.5.2. Power Of Buyers

    4.5.3. Threat Of Substitutes

    4.5.4. Threat Of New Entrants

    4.5.5. Competitive Rivalry

Chapter 5. MICRORNA (MIRNA) MARKET BY Tools Type INSIGHTS & TRENDS

5.1. Segment 1 Dynamics & Market Share, 2019 & 2027

5.2. qRT-PCR

    5.2.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

    5.2.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

5.3. Biomarkers

    5.3.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

    5.3.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

Chapter 6. MICRORNA (MIRNA) MARKET BY Services Type INSIGHTS & TRENDS

6.1. Segment 2 Dynamics & Market Share, 2019 & 2027

6.2. Microarray Services

    6.2.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

    6.2.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

6.3. Functional Studies Services

    6.3.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

    6.3.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

Chapter 7. MICRORNA (MIRNA) MARKET REGIONAL OUTLOOK

7.1. MicroRNA (miRNA) Market Share By Region, 2019 & 2027

7.2. NORTH AMERICA

    7.2.1. North America MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.2.2. North America MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.2.3. North America MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.2.4. North America MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.2.5. U.S.

    7.2.5.1. U.S. MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.2.5.2. U.S. MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.2.5.3. U.S. MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.2.5.4. U.S. MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.2.6. CANADA

    7.2.6.1. Canada MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.2.6.2. Canada MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.2.6.3. Canada MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.2.6.4. Canada MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3. EUROPE

    7.3.1. Europe MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.3.2. Europe MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.3.3. Europe MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.3.4. Europe MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3.5. GERMANY

    7.3.5.1. Germany MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.3.5.2. Germany MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.3.5.3. Germany MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.3.5.4. Germany MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3.6. FRANCE

    7.3.6.1. France MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.3.6.2. France MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.3.6.3. France MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.3.6.4. France MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3.7. U.K.

    7.3.7.1. U.K. MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.3.7.2. U.K. MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.3.7.3. U.K. MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.3.7.4. U.K. MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4. ASIA-PACIFIC

    7.4.1. Asia Pacific MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.4.2. Asia Pacific MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.4.3. Asia Pacific MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.4.4. Asia Pacific MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

 7.4.5. CHINA

     7.4.5.1. China MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

     7.4.5.2. China MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

     7.4.5.3. China MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

     7.4.5.4. China MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4.6. INDIA

     7.4.6.1. India MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

     7.4.6.2. India MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

     7.4.6.3. India MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

     7.4.6.4. India MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4.7. JAPAN

     7.4.7.1. Japan MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

     7.4.7.2. Japan MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.4.7.3. Japan MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.4.7.4. Japan MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4.8. AUSTRALIA

    7.4.8.1. Australia MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.4.8.2. Australia MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

     7.4.8.3. Australia MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.4.8.4. Australia MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.5. MIDDLE EAST AND AFRICA (MEA)

    7.5.1. Mea MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.5.2. Mea MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.5.3. Mea MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.5.4. Mea MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.6. LATIN AMERICA

     7.6.1. Latin America MicroRNA (miRNA) Market Estimates And Forecast, 2016 – 2027, (USD Million)

    7.6.2. Latin America MicroRNA (miRNA) Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

    7.6.3. Latin America MicroRNA (miRNA) Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

    7.6.4. Latin America MicroRNA (miRNA) Market Estimates And Forecast By Production Process, 2016 –2027, (USD Million)

    7.6.5. Latin America MicroRNA (miRNA) Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Market Share By Manufacturers

8.2. Strategic Benchmarking

    8.2.1. New Product Launches

    8.2.2. Investment & Expansion

    8.2.3. Acquisitions

    8.2.4. Partnerships, Agreement, Mergers, Joint-Ventures

8.3. Vendor Landscape

     8.3.1. North American Suppliers

     8.3.2. European Suppliers

     8.3.3. Asia-Pacific Suppliers

     8.3.4. Rest Of The World Suppliers

Chapter 9. COMPANY PROFILES

9.1. Agilent Technologies

    9.1.1. Company Overview

    9.1.2. Financial Performance

    9.1.3. Product Insights

    9.1.4. Strategic Initiatives

9.2. Alnylam Pharmaceuticals

    9.2.1. Company Overview

    9.2.2. Financial Performance

    9.2.3. Product Insights

    9.2.4. Strategic Initiatives

9.3. Bio-Rad Laboratories

    9.3.1. Company Overview

    9.3.2. Financial Performance

    9.3.3. Product Insights

    9.3.4. Strategic Initiatives

9.4. GeneCopoeia, Inc

    9.4.1. Company Overview

    9.4.2. Financial Performance

    9.4.3. Product Insights

    9.4.4. Strategic Initiatives

9.5. Illumina, Inc

    9.5.1. Company Overview

    9.5.2. Financial Performance

    9.5.3. Product Insights

    9.5.4. Strategic Initiatives

9.6. Merck KGaA

    9.6.1. Company Overview

    9.6.2. Financial Performance

    9.6.3. Product Insights

    9.6.4. Strategic Initiatives

9.7. Miltenyi Biotec

    9.7.1. Company Overview

    9.7.2. Financial Performance

    9.7.3. Product Insights

    9.7.4. Strategic Initiatives

9.8. NanoString Technologies, Inc

    9.8.1. Company Overview

    9.8.2. Financial Performance

    9.8.3. Product Insights

    9.8.4. Strategic Initiatives

9.9. New England Biolabs

    9.9.1. Company Overview

    9.9.2. Financial Performance

    9.9.3. Product Insights

    9.9.4. Strategic Initiatives

9.10. QIAGEN (Exiqon)

    9.10.1. Company Overview

    9.10.2. Financial Performance

    9.10.3. Product Insights

    9.10.4. Strategic Initiatives

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?
Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Request for customization
Report Snapshot
Free Sample Report

"Find new revenue generation opportunities"